459 results on '"Nakatsuji, T."'
Search Results
2. Comparison of Adverse Event Profiles of Tumor Necrosis Factor-Alfa Inhibitors: Analysis of a Spontaneous Reporting Database
3. 943 Loss of both host-derived antimicrobial peptides and bacteriocin-producing commensals enables survival of Staphylococcus aureus on Th2-inflamed skin
4. 626 Clinical trial of bacteriotherapy as antibiotic-sparing therapy for acne vulgaris
5. 347 A machine learning analysis enables demonstration that fibroblasts mediate neutrophil recruitment during type 17 skin inflammation
6. 349 Functional screening of Cutibacterium acnes isolates reveal determinants of skin inflammation.
7. Anisotropy of Longitudinal Wave Velocity in Spherically Shaped Bovine Cortical Bone
8. Inferring driver’s deceleration intent in vehicle platoon system by using feedback estimators
9. 525 How the inappropriate innate immune response of atopic dermatitis promotes dysbiosis of the skin microbiome
10. 830 Topical ivermectin modulates the skin microbiome and improves symptoms of rosacea
11. 451 Effects of commonly used topical moisturizers on the survival of staphylococcus aureus and staphylococcus hominis A9: Key contributors to the atopic dermatitis microbiome
12. 071 IL4/13 activates dermal fibroblasts to decrease host defense and further promote Th2 inflammation
13. 073 Fibroblasts are a major cell type in the skin that responds to keratinocyte interleukin-1
14. Prediction for Truck Endurance from the Basis of Road Profile Measurements
15. 207 Targeting of HDAC8 and HDAC9 in keratinocytes to enhance skin immune defense
16. 483 Antimicrobials from a feline skin commensal bacterium inhibits drug-resistant S. pseudintermedius skin colonization and infection
17. The effects of suppressed expression of metabotropic glutamate receptor 5 (mGluR5) and accelerated expression of Fas ligand (FasL) mRNA on bone marrow (BM)/liver grafts in rat
18. High levels of serum soluble CD27 correlated with renal dysfunction
19. 813 Metabolic products of Cutibacterium acnes protect against cutaneous biofilm formation by Staphylococci
20. 337 Innate immune tolerance of the epidermis is mediated by epigenetic regulation of MAP2K3
21. 598 Identification of a human skin commensal bacterium that selectively kills cutibacterium acnes
22. 327 Staphylococcus epidermidis protease EcpA is a deleterious component of the skin microbiome in atopic dermatitis
23. 860 Microbiome therapy of atopic dermatitis by application of rationally selected human commensal skin bacteria
24. 363 Systemic sphingosine 1-phosphate receptor 2 (S1PR2) deficiency facilitates dermal neutrophil infiltration against S. aureus infection
25. 400 Staphylococccus epidermidis can exacerbate atopic dermatitis through the secretion of the cysteine protease EcpA
26. 102 Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Patients With Atopic Dermatitis
27. 489 Apple cider vinegar: a promising adjunctive anti-staphylococcal treatment in atopic dermatitis
28. 310 Staphylococccus epidermidis cysteine protease EcpA is an epidermal barrier penetration enzyme
29. 473 Competition between AMP kingdoms in atopic dermatitis leads to depletion of the defense function of the skin microbiome against S. aureus
30. Dynamic Behavior of a Vehicle on a Rutted Road
31. Hybrid composites with self-diagnosing function for preventing fatal fracture
32. LB1571 Effects of SB414 cream on S. aureus and tissue cytokines in an atopic dermatitis mouse model
33. LB1505 Dupilumab-mediated IL-4Rα blockade decreases Staphylococcus aureus colonization and increases microbial diversity in patients with Atopic Dermatitis (AD)
34. LB1557 Lantibiotics from human skin commensal bacteria defend against multiple Gram-positive bacterial skin pathogens
35. LB1554 Bleach does not kill Staphylococcus aureus on skin; A comparison of bactericidal effects of bleach on individual bacterial cells versus cultured bacteria
36. 920 Quorum sensing between bacterial species on skin protects against barrier disruption and inflammation promoted by Staphyloccocus aureus
37. 426 Clinical improvement in atopic dermatitis following autologous application of microbiome therapy targeting Staphylococcus aureus
38. A highly durable catalytic NOx reduction in the presence of SOx using periodic two steps, an operation in oxidizing conditions and a relatively short operation in reducing conditions
39. Human Class II Antigen in Different Ethnic Groups
40. 636 Commensal skin bacteria inhibit the capacity of Staphylococcus aureus to induce epidermal serine protease activity in atopic dermatitis
41. 612 Specific strains of S. epidermidis suppress UV-induced skin tumor formation by production of 6- N -hydroxyaminopurine, a DNA synthesis inhibitor
42. Safety profile of vonoprazan compared with proton pump inhibitors: insight from a pharmacovigilance study
43. PLT Analysis of D Region Complexity by Cloned Cells: A New Non-DP Antigen
44. 373 Dupilumab improves clinical atopic dermatitis parameters and modulates specific IgEs and Staphylococcus aureus abundance
45. 484 Staphylococcus aureus exploits barrier defects in atopic dermatitis to trigger skin inflammation
46. 314 The cutaneous microbiome controls epidermal protease activity
47. 273 Establishment of an autologous microbiome transplant in atopic dermatitis targeting Staphylococcus aureus
48. 739 Hyaluronan controls adipogenesis following skin injury
49. 270 Resilience of AMPs and the cutaneous microbiome to treatment with topical cleansers
50. The frequency of the γ chain variant AγT in different populations, and its use in evaluating γ gene expression in association with thalassemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.